BioChem Adda

Future proof your biotech career with the required skills - Admissions Open - Biocon KGI Certificate Program in Biosciences - mailchi.mp/890157e5706b/a…

Just posted a photo instagram.com/p/CXAj7jVlEiD/…

Learn the applied knowledge on various Good Regulatory Practices (GRA) - Admissions Open for Certificate Program in GRA - mailchi.mp/a28d0700fa8e/a…

Biocon Ramaiah Certificate Program in QC Analytical, Batch 3 - mailchi.mp/c2aaa68146a9/a… Please mention @BioChemAdda while applying to this program. admission.bioconacademy.com/ApplicantLogin…)

Just posted a photo instagram.com/p/CMwCXnBLOSw/…

$ARVN - Arvinas to Present at the Guggenheim Healthcare Talks: 2021 Oncology Day ir.arvinas.com/news-releases/…

$AUTL - Autolus Announces Proposed Public Offering in the United States autolus.gcs-web.com/news-releases/…

$CSII - First Patient in Europe Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System investors.csi360.com/news-releases/…

$CORT - Corcept Therapeutics Announces Fourth Quarter, Full-Year 2020 Preliminary Selected Financial Results and 2021 Revenue Guidance; Provides Corporate Update ir.corcept.com/news-releases/…

$NAVB - Navidea Biopharmaceuticals Announces Submission of Formal Type B Meeting Request with FDA and Launch of NAV3-32 Phase 2B Trial in Rheumatoid Arthritis navidea.com/news-media/pre…

$AVIR - Atea Pharmaceuticals Announces Publication of Preclinical Data Highlighting Potent Activity of AT-527 Against SARS-CoV-2 ir.ateapharma.com/news-releases/…

$RVMD - Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares benzinga.com/pressreleases/…

$IRWD - Ironwood Pharmaceuticals Announces CEO Transition benzinga.com/pressreleases/…

$ENTA - Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2020 with Webcast and Conference Call Today at 4:30 p.m. ET benzinga.com/pressreleases/…

$BXRX - Baudax Bio Announces $17.6 Million Offering Priced At-the-Market under Nasdaq Rules benzinga.com/pressreleases/…

$SRNE - Sorrento Announces Subsidiary Company - ADNAB, Inc. - to Develop and Commercialize ADNAB™ Platform Products for Hematological Malignancies and Solid Tumors Based on an Exclusive Technology License From the Mayo Clinic - manufacture of antibody-drug conjugates (ADC)

$FOLD - Amicus Therapeutics Announces Positive Initial Clinical Data for CLN3 Batten Disease Gene Therapy at the 17th Annual WORLDSymposium™ 2021

#biowar $SRNE Prospects Look Bright. Several COVID-19 therapeutics plus diagnostic tests.

Hey @WSBChairman... please suggest... $srne is it worth (to the moon). Currently in $12-13 range. But few analysts project it to be worth of $35.

A recent study coming from #France found no evidence of a strong antiviral activity or clinical benefit of the combination of #hydroxychloroquine and #azithromycin for the treatment of hospitalized patients with severe #COVID19 #coronavirus #COVID sciencedirect.com/science/articl…